skip to primary navigationskip to content
 

Taking parked therapies into overdrive

last modified Apr 28, 2014 04:09 PM
Healx3 is aiming to breathe new life into parked therapeutics and dormant IP in the biopharmaceutical industry.

 

The start-up, based at ideaSpace West, hopes to take the medical technology parked by biopharmaceutical companies and turn it into new drugs and therapies. Healx3 is currently in talks with biopharma companies on potential partnerships.

In an interview with Business Weekly, CEO Tim Guilliams, who holds a PhD in molecular neuroscience from the University of Cambridge, says: “Around 90 per cent of drug development projects never make it to market – leaving a vast amount of parked bio-assets on company benches.

“Some of these assets still have therapeutic potential, but do not cure patients or generate revenue. Healx3 is specialising in the upcycle and out-licensing of parked therapeutics and dormant IP in the biopharmaceutical industry.

“By enabling companies to generate new revenue streams and promote collaborative innovation within the industry, our activities will help deliver the next generation of therapeutics to patients in need.”

Healx3 is currently self-funded but aims to seek angel support once it has created strategic partnerships, launching a pilot with around 10 assets and pushing for seed capital around September.

To read the full article visit here

For more on Healx3 see http://www.healx3.com/

RSS Feed Latest news

GeneAdviser partners with Birmingham Women’s Hospital to make personalised medicine more accessible

Sep 29, 2016

The largest genetics laboratory in the NHS brings to the platform their solid tumour sequencing, enabling clinicians to give an individual approach to their patients, tailored to their tumour’s genetic makeup.

GeneAdviser raises £350K to boost uptake of genomic medicine

Jun 02, 2016

GeneAdviser, an online ordering platform for clinical genetic testing, has raised £350,000 in its first round of seed funding, backed by Cambridge biotech angel Dr Jonathan Milner.

ROADMAP Systems secures $1.7m in Series A investment

Apr 08, 2016

ideaSpace member and ROADMap CEO Karl Heeks ready to take revolutionary wavelength switch technology to market

Metrarc wins funding from Innovate UK for data protection research

Mar 31, 2016

Cambridge-based Metrarc is part of a consortium which has won funding worth nearly £400,000 from Innovate UK to combat growing security threats to the management of personal health data.

View all news